medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2004, Number 4

<< Back Next >>

Rev Biomed 2004; 15 (4)

Cancer of the cervix: current detection methods

Dzul-Rosado KR, Puerto-Solís M, González-Losa MR

Language: Spanish
References: 54
Page: 233-241
PDF size: 42.16 Kb.


ABSTRACT

Cancer of the cervix is an important health problem, It is the second cause of death by neoplasia worldwide, and the first cause in developing countries. During the last decades cancer of the cervix has been most frequent type of neoplasia and the first cause of death by cancer among Mexican women over 35.
The slow evolution of the disease and the accessibility of the cervix cells for diagnosis allow doctors time and methods to detect and cure the pathology if the diagnosis is timely; which makes cancer of the cervix 100% preventative.
Pap smears, colposcopy, histopatology, and molecular tests for papillomavirus DNA are methods used for diagnosis of cervical cancer. They are complementary but they are all a part of the studies done on woman with cervical pathology, and each one has a special indication.
The aim of the article is to provide current information about the methods used for the diagnosis of cancer of the cervix, and the value of each one in the fight against this neoplasia, which continues to be a lash against twenty-first century women.


REFERENCES

  1. Eluf-Neto J, Nascimento CM. Cervical Cancer in Latin America. Sem Oncol 2001;28:188-97.

  2. Kiviat N. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996; 175:1099-104.

  3. Hadzic B, Hadzic M, Curcin N. Histologic classification and terminology of precancerous lesions of the cervix. Med Pregl 1999; 52: 151-5.

  4. Broso PR, Buffetti G. The Papanicolaou classification in the Bethesda System (National Cancer Institute, Bethesda, Maryland). Minerva Ginecol 1993; 45: 557-63.

  5. Cox JT. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA 1999; 281:1645-7.

  6. Cox JT, Lorincz A, Shiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172:946-54.

  7. Norma Oficial Mexicana. Disponible en: www.hgm.salud.gob.mx/servmed/nom_014_ssa2_1994.pdf

  8. Maisavana JML, Muniesa- Soriano JA, Pardo-Murcia A. Citología exfoliativa cervicovaginal (Método de Papanicolaou). Boletín Oncológico No 8/1998. Disponible en: www.opolanco.es/Apat/Boletin2/CITOLOGIA.html

  9. Dirección General de Estadística e Informática de la Secretaria de Salud, México. Principales resultados de la estadística sobre mortalidad en México, 1995. Salud Pública México 1997; 39: 85-91.

  10. Lazcano- Ponce E, Rascón-Pacheco R, Lozano-Ascencio R, Velasco-Mondragón HE. Mortality from carcinoma of the uterine cervix in Mexico : Impact of screening 1980-1990. Acta Cytol 1996; 40 : 506-12.

  11. Demay RM. Cytopathlogy of false negatives preceding cervical carcinoma. Am J Gynecol 1996; 175: 1110-13.

  12. Hilgarth M. Sampling and processing in gynaecological cytology. Cancer Res 1993; 133:99-104.

  13. Kristensen GB, Skyggebjerg KD, Holund B, Holm K, Hansen MK. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Act Cytol 1991; 35:47-50.

  14. Lazcano E, Alonso P, López L, Hernández M. Quality control study on negative gynaecological cytology in Mexico. Diag Cytophato 1994; 10:10-14.

  15. Gay JD, Donaldoson LD, Goellner DR. False negative result cervical cytologic studies. Act Cytol 1985; 29:1043-6.

  16. Lazcano E, Alonso P, López Cl, Nájera AP, Ávila CR, Escandón RC, et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytol 1997; 41:277-84.

  17. Malle D, Pateinakis P, Chakka E, Destouni C. Experience with a thin-layer, liquid-based cervical cytologic screening method. Acta Cytol 2003; 47:129-34.

  18. Mango LJ. Reducing false negatives in clinical practice: The role of neural network technology. Am J Gynecol 1996; 175: 1114-9.

  19. Walts AE, Thomas P. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears. Diagn Cytopathol. 2002; 27:232-7.

  20. Krieger PA, Mcgoogan E, Vooijs GP, Amma NS, Cochand- Priollet B, Colgan TJ, et al. Quality assurance/control issues. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998; 42:133-40.

  21. Nuovo J, Melnikow J, Howell LP. New test cervical screening. Am Fam Phys 2001; 64:780-6

  22. Ferris DG. Officer procedures. Primary Care: Clin Office Prac 1997; 24: 241-67.

  23. Dexeus S, Cararach M, Dexeus D. The role of colposcopy in modern gynecology. Eur J Gynaecol Oncol 2002; 23:269-77.

  24. Ferris DG, Greenberg MD. Red’s colposcopic index. J Fam Prac 1994; 39: 65-70.

  25. Coppleson M, Dalrymple Jc, Atikinson K H. Diferenciación colposcópica de anomalías que surgen en la zona de transformación. En: Clínicas de Ginecología y Obstetricia. Temas actuales. Colposcopía. México: McGraw Hill-Interamericana; 1993:83-103.

  26. Reid R. Biología y características colposcópicas de la enfermedad cervicouterina vinculada con el virus del papiloma humano. En: Clínicas de Ginecología y Obstetricia. Temas actuales. Colposcopía. México: McGraw Hill-Interamericana; 1993:117-41.

  27. Lickrish GM, Colgan TI, Wrigt VC. Colposcopía del adenocarcinoma in situ y del invasor del cuello uterino. En: Clínicas de Ginecología y Obstetricia. Temas actuales. Colposcopía. México: McGraw Hill-Interamericana; 1993:105-13.

  28. Pete I, Toth V, Bosze P. The value of colposcopy in screening cervical carcinoma. Eur J Gynaecol Oncol 1998; 19: 120-2.

  29. Bajwa R, Khan Sa, Qureshi GR, Chaudrhy NA. Colposcopy in the diagnosis of human papillomavirus infection, cervical intraepitelial neoplasia and invasive carcinoma. JPMA 1993; 43:257-8.

  30. Korkolopoulou P, Kolokythas C, Kittas C, Alevritou H, Pavlakis K. Correlation of colposcopy and histology in cervical biopsies positive for CIN and or HPV infection. Eur J Gynecol Oncol 1992;13:502-6.

  31. Ceccini S, Bonardi R, Lossa A, Zapata M, Ciatto S. Colposcopy as a primary screening test for cervical cancer. Tumori 1997; 83:810-3.

  32. Gullota G, Margariti PA, Rabitti C, Balsamo G, Valle D, Capelli A, Mancuso S. Cytology, histology and colposcopy in the diagnosis off neoplasic non invasive epithelial lesion of the cervix. Eur J Gynaecol Oncol 1997; 18:36-8.

  33. Carta G, DI Stefano L, Castellani Perelli A, Toro G, Moscarini M. Colposcopy, cytology and histology in the diagnosis of squamous intraepithelial lesions of the cervix. Clin Exp Obstet Gynecol 1999; 26: 60-6.

  34. Zamudio-Andrade A, Zepeda- Zaragoza J, Rodríguez-Blanco B, Tenorio Marañón R. Evaluación del Papanicolaou y la colposcopía en el diagnóstico de la infección por el virus del papiloma humano. En: Clínicas de Ginecología y Obstetricia. Temas actuales. México: McGraw Hill-Interamericana; 1999: 60-66.

  35. Zahm DM, Nindl I, Greinke C, Hoyer H, Schneider A. Colposcopic appearance of cervical intraepithelial neoplasia is age dependent. Am J Obstet Gynecol 1998; 179:1298-304.

  36. Morris M, Tortolero-Luna G, Nalpica A, Bacher VV, Cook E, Johnson E, Mitchell MF. Neoplasia intraepitelial y cáncer cervicouterino. En: Clínicas de Ginecología y Obstetricia. Temas actuales. Prevención del cáncer ginecológico. México: McGraw Hill-Interamericana; 1996:315-39.

  37. Massad LS, Collins YC. Strength of correlations between colposcopic impression and biopsy histology. Gynecol Oncol 2003; 89:424-8.

  38. Depriest PD, Van Nagell JR, Powell DE. Microinvasive cervical cancer. Clin Obstet Gynecol 1990; 33:846-51.

  39. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study of Cervical Cancer (IBSCC) Study group. J Natl Cancer Inst 1995; 87 :796-802.

  40. Lörincs AT, Reid R, Jenson B, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-37.

  41. Wick MJ. Diagnosis of human papillomavirus gynaecologic infections. Clin Lab Med 2000; 20:271-87.

  42. Jenkins D. Diagnosing human papillomaviruses: recents advances. Curr Opin Infect Dis 2001; 14:53-62.

  43. Castle PE, Lorincz AT Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, et al. Results of human papillomavirus DNA testing with hybrid capture 2 assay are reproducible. J Clin Microbiol 2002; 40:1088-90.

  44. Ronco G. Use of molecular test of human papilloma virus (HPV) as screening test for cervix cancer: A review. Epidemiol Prev 1999; 23:372-7.

  45. Lorincz A. Diagnosis of human papillomavirus infection by new generation of molecular DNA assays. Clin Immunol News 1992; 12:123-8.

  46. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995; 85:202-10.

  47. Brown DR Cramer H, Fife KH. Analysis of human papillomavirus types in exophytic condylomata acuminata by hybride capture and Southern Blot techniques. J Clin Microbiol 1993; 31:2667-73.

  48. Fait G, Kupferminc MI, Daniel Y, Geva E, Ron IG, Lessing JB, et al. Contribution of human papillomavirus testing by hybrid capture in triage of women with repeated abnormal pap smears before colposcopy referral. Gynecol Oncol 2000; 79:177-80.

  49. Lin Ct, Tseng CI, Lai CH, Husueh S, Huang Hj, Law KS. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or =50 years age. J Reprod Med 2000; 45:354-60.

  50. Clavel C, Masure M, Putaud I, Thomas K, Bory JP, Gabriel R, et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR result in cervical lesions. J Clin Pathol 1998; 51:737-40.

  51. Farthing A, Masterson P, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994; 47:649-52.

  52. Manos M, Kinney W, Hurley L, Sherman M, Shieh-Ngai J, Kurman R, et al. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal papanicolaou results. JAMA 1999; 281:1605-10.

  53. Wrigth T, Denny L, Kuhn L, Pollack A, Lorincz A. PVH DNA testing of self-collected vaginal samples comparated with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-6.

  54. Ramizi RF, Irani-Hakime N, Tamin H, Almawi WY. Validity of vaginal testing in detecting human papillomavirus (HPV) genotypes. J Clin Virol 2000; 19:163-8.




2020     |     www.medigraphic.com